← Back to ABEO

Abeona Therapeutics Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 13/05/2026Sep 2025Filed 12/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 13/05/2026Sep 2024Filed 12/11/2025Jun 2024Filed 14/08/2025Mar 2024Filed 15/05/2025
$11$8.7$1.7$0.4$1.3$1.2$1.2$0.8
−$20−$17−$5.2$109−$12−$30$7.4−$32
−$0.35−$0.30−$0.10$1.71−$0.24−$0.63−$0.26−$1.16
5757546750485127

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.